CVS analyst estimates
CVS Health (CVS) analyst ratings, the average price target and its range, and every firm's latest call.
CVS analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | Leerink Partners | CVS Health price target lowered to $112 from $119 at Leerink | $112.00 |
| Sep 9, 2026 | Piper Sandler | CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group | $112.00 |
| Sep 9, 2026 | BMO Capital | CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group | $112.00 |
| Sep 9, 2026 | Bernstein | CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group | $112.00 |
| Sep 3, 2026 | UBS | CVS Health price target lowered to $118 from $126 at UBS | $118.00 |
| Aug 19, 2026 | Argus Research | CVS Health price target raised to $114 from $104 at Argus | $114.00 |
| Aug 6, 2026 | Barclays | CVS Health price target raised to $108 from $106 at Barclays | $108.00 |
| Aug 6, 2026 | UBS | CVS Health (CVS) PT Raised to $126 at UBS | $126.00 |
| Aug 6, 2026 | Robert W. Baird | CVS Health price target raised to $107 from $94 at Baird | $107.00 |
| Jul 24, 2026 | UBS | CVS Health price target raised to $122 from $115 at UBS | $122.00 |
| Jul 14, 2026 | Truist Financial | CVS Health price target raised to $118 from $108 at Truist | $118.00 |
| Jul 13, 2026 | Wells Fargo | CVS Health price target raised to $123 from $103 at Wells Fargo | $123.00 |
| Jul 9, 2026 | RBC Capital | CVS Health price target raised to $113 from $107 at RBC Capital | $113.00 |
| Jul 7, 2026 | Cantor Fitzgerald | CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post ChecksMember Login | $110.00 |
| Jul 6, 2026 | HSBC | CVS Health price target raised to $103 from $85 at HSBC | $103.00 |
- 17 firms rate CVS: 17 buy, 0 hold, 0 sell.
- The average price target is $112.46 from 13 analysts, from $103.00 to $123.00.
Updated 2026-11-02 17:13 UTC